Is Tattooing an Injection? Evaluating the Mechanics of Ink Placement
Source abstract
Abstract
Guidance recently released by the Food and Drug Administration (FDA) regarding tattoo inks describes tattooing as an injection process, but is injection the correct terminology to use when describing tattooing? This perspective aims to provide a brief overview of the core mechanics and science behind injection and tattoo processes, as well as emphasize the importance of using the correct terminology when referencing tattoos and the act of tattooing moving forward. STATEMENT OF SIGNIFICANCE: Due to a change in the FDA regulatory framework around cosmetics in December 2022, for the first time the FDA is in the process of actively regulating tattoo inks. Central to how tattoos will be regulated is whether tattoos and tattooing should be considered an injectable process. If tattoos are injectables, then tattoo inks would be considered within a medical device framework leading to a radical alteration tattoo industry in the US and globally. This perspective surveys the literature to understand what it means for something to be "injected" and then compares that to the state-of-the-art understanding about how tattoos are deposited in the skin. Based on this analysis, it is clear that tattooing should not be described as an injection process.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tattoo and Body Piercing Complications · Body Image and Dysmorphia Studies · Dermatologic Treatments and Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. Kosut, M. (2003). The art of tattoo: from outsider culture to institutionalization. ProQuest Dissertations & Theses.
2. A medical-toxicological view of tattooing10.1016/S0140-6736(15)60215-X ↗
3. Tattoos and body piercings in the United States: a national data set10.1016/j.jaad.2006.03.026 ↗
4. Visualization of drug delivery via tattooing: effect of needle reciprocating frequency and fluid properties10.1007/s12650-021-00816-5 ↗
5. Food and Drug Administration Center for Food Safety and Applied Nutrition, FDA-2023-d-1083, insanitary conditions in the preparation, packing, and holding of tattoo inks and the risk of microbial contamination: guidance for industry. Rockville, MD; Food and Drug Administration.
6. Center for Devices and Radiological Health. (2023, July 6). Dermal fillers (Soft tissue fillers). U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/dermal-fillers-soft-tissue-fillers.
7. 21 CFR part 878 – general and plastic surgery devices. (n.d.). https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-878.
8. Drawing on popular culture: using tattooing to introduce biological concepts10.1525/abt.2012.74.6.5 ↗
9. Natural mummies from predynastic Egypt reveal the world’s earliest figural tattoos10.1016/j.jas.2018.02.002 ↗
10. Tattoo: a cultural heritage
11. Investigation and experimentation on ancient Egyptian tattooing methods10.1515/zaes-2021-0107 ↗
12. Embodying the divine: a tattooed female mummy from Deir el-Medina
13. Identifying the practice of tattooing in ancient Egypt and Nubia
14. Possible tattooing instruments in the Petrie Museum10.1177/030751330108700114 ↗
15. Ancient tattooing in Polynesia10.1080/15564894.2018.1561558 ↗
16. Hugh S. Stannus, The practice of scarification (tattooing) among the natives of Nyasaland, n.d. Source: The Royal Anthropological Institute of Great Britain and Ireland https://app.wileydigitalarchives.com/wiley/detail/RAIMFA250-C0001-MA000001.
17. What's in my ink: an analysis of commercial tattoo ink on the US market10.1021/acs.analchem.3c05687 ↗
18. How much medication is delivered in a novel drug delivery technique that uses a tattoo machine?10.1111/ijd.14408 ↗
19. Tattoo ink nanoparticles in skin tissue and fibroblasts10.3762/bjnano.6.120 ↗
20. Tat_BioV: tattoo ink exposure and biokinetics of selected tracers in a short-term clinical study of 24 subjects10.1007/s00204-025-03959-8 ↗
21. 3D Nipple–areolar tattoo: it’s technique, outcomes, and utilization10.1007/s00266-020-01967-w ↗
22. A medical tattooing technique for enhancing the three-dimensional appearance of the nipple-areola complex after flap-based nipple reconstruction10.1007/s00266-021-02471-5 ↗
23. Invited discussion on: 3D nipple–areolar tattoo: its technique, outcomes, and utilization10.1007/s00266-020-02034-0 ↗
24. Tattooing: medical uses and problems10.3949/ccjm.79a.12016 ↗
25. Endoscopic hemostatic devices10.1016/j.gie.2008.12.251 ↗
26. Endoscopic tattooing10.1016/j.gie.2010.06.020 ↗
27. Preoperative ultrasound-guided tattooing localization of recurrences after thyroidectomy: safety and effectiveness10.1245/s10434-009-0431-7 ↗
28. Q-switched ruby laser treatment of traumatic tattooing induced by pencil point puncture in children10.1111/j.1525-1470.1997.tb00969.x ↗
29. Solar freckles: long-term photochromic tattoos for intradermal ultraviolet radiometry10.1021/acsnano.0c05723 ↗
30. Fluorescent dermal tattoo biosensors for electrolyte analysis10.1016/j.snb.2020.128378 ↗
31. Wearable electrochemical sensors and biosensors: a review10.1002/elan.201200349 ↗
32. Tattooing soft biological matter10.1038/s41578-023-00594-6 ↗
33. DeMarco, S., PhD. (2022, October 12). Tattoo therapeutics deliver medicine more than skin deep. drug discover news drug discovery news, development & diagnostics articles | DDN magazine. https://www.drugdiscoverynews.com/tattoo-therapeutics-deliver-medicine-more-than-skindeep-15525.
34. How much medication is delivered in a novel drug delivery technique that uses a tattoo machine?10.1111/ijd.14408 ↗
35. Office of the Commissioner. (2025, January 17). Modernization of Cosmetics Regulation Act of 2022 (MOCRA). U.S. Food and Drug Administration. https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra.
36. 21 Usc chapter 9, subchapter ii: definitions. (n.d.). https://uscode.house.gov/view.xhtml?path=/prelim@title21/chapter9/subchapter2&edition=prelim.
37. Center for Devices and Radiological Health. (2022, August 10). Color additives for medical devices. U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/biocompatibility-assessment-resource-center/color-additives-medical-devices.
38. Office of the Commissioner. (2023, July 13). How safe are color additives? U.S. Food and Drug Administration. https://www.fda.gov/consumers/consumer-updates/how-safe-are-color-additives.
39. See consolidated appropriations act, 2023, Pub. L. No. 117-328, § 3502 (2022).
40. Center for Devices and Radiological Health. (2022b, September 29). How to determine if your product is a medical device. U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/classify-your-medical-device/how-determine-if-your-product-medical-device.
41. NCI Dictionary of Cancer Terms. (n.d.). Cancer.gov. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/injection.
42. injection | Taber’s Medical Dictionary. (n.d.). https://www.tabers.com/tabersonline/view/Tabers-Dictionary/757723/all/injection.
43. Doyle, G.R., & McCutcheon, J.A. (2015a, November 23). 7.3 Intradermal and subcutaneous injections. Pressbooks. https://opentextbc.ca/clinicalskills/chapter/6-7-intradermal-subcutaneous-and-intramuscular-injections/.
44. Doyle, G.R., & McCutcheon, J.A. (2015a, November 23). 7.4 intramuscular injections. Pressbooks. https://opentextbc.ca/clinicalskills/chapter/6-8-iv-push-medications-and-saline-lock-flush/.
45. Doyle, G.R., & McCutcheon, J.A. (2015, November 23). 7.5 intravenous medications by direct IV route. Pressbooks. https://opentextbc.ca/clinicalskills/chapter/6-9-iv-main-and-mini-bag-medications/.
46. Clinical testing guidance for tuberculosis: Tuberculin skin test. (2025, January 31). Tuberculosis (TB). https://www.cdc.gov/tb/hcp/testing-diagnosis/tuberculin-skin-test.html?CDC_AAref_Val=https://www.cdc.gov/tb/publications/factsheets/testing/skintesting.htm.
47. Deep penetration and liquid injection into adipose tissue10.2140/jomms.2011.6.127 ↗
48. Non-invasive in vivo quantification of human skin tension lines10.1016/j.actbio.2019.02.003 ↗
49. Puncture of elastomer membranes by medical needles. Part I: mechanisms10.1007/s10704-009-9326-7 ↗
50. Mechanics and mechanisms of puncture by medical needles10.1016/j.proeng.2009.06.032 ↗
51. High speed imaging of solid needle and liquid micro-jet injections10.1063/1.5074176 ↗
52. Current status and future prospects of needle-free liquid jet injectors10.1038/nrd2076 ↗
53. Dynamic interaction of injected liquid jet with skin layer interfaces revealed by microsecond imaging of optically cleared ex vivo skin tissue model10.1186/s13036-023-00335-x ↗
54. Ocular and periocular tattoo adverse effects: a review10.3390/diagnostics14192150 ↗
55. Lessons learned in a decade: medical-toxicological view of tattooing10.1111/jdv.20072 ↗
56. Cellular mechanisms of skin repair in humans and other mammals10.1007/s12079-016-0330-1 ↗
57. Modern tattoos cause high concentrations of hazardous pigments in skin10.1111/j.1600-0536.2007.01301.x ↗
58. Tattooing of skin results in transportation and light-induced decomposition of tattoo pigments - a first quantification in vivo using a mouse model10.1111/j.1600-0625.2009.00925.x ↗
59. Safety of tattoos and permanent make-up: a regulatory view10.1007/s00204-020-02655-z ↗
60. TATTCOM. (2022, November 30). How is a tattoo line formed? Tattoo physics [Video]. YouTube. https://www.youtube.com/watch?v=4EGxPLBrpUw.
61. Microneedle patch tattoos10.1016/j.isci.2022.105014 ↗
62. Microneedles as a promising technology for disease monitoring and drug delivery: a review10.1021/acsmaterialsau.4c00125 ↗
63. Shio, M.T., Paquet, M., Martel, C., Bosschaerts, T., Stienstra, S., Olivier, M., & Fortin, A. (2014). Drug delivery by tattooing to treat cutaneous leishmaniasis. Sci. Rep, 4(1), Article 4156. https://doi.org/10.1038/srep04156.10.1038/srep04156 ↗
64. DNA vaccines and intradermal vaccination by DNA tattooing
65. Corneal drug delivery with tattoo technique: a new route for intrastromal cornea administration10.4103/pajo.pajo_45_23 ↗